Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a personal history of uveal melanoma (a type of eye cancer), whether newly diagnosed, currently being treated, or in a follow-up phase
- People who are enrolled in or receiving benefits from a social security scheme
Who may not be able to join:
- People who have already been found to have a specific harmful gene change in either the BAP1 or MBD4 gene
- People who do not agree to have their genetic material (DNA) analysed for diagnostic purposes
- People who do not agree to have their genetic material (DNA) analysed for research purposes
- People who are pregnant or currently breastfeeding
- People who are under legal guardianship or trusteeship (a legal arrangement where another person or authority has been appointed to make decisions on their behalf)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mathis LEPAGE, Dr, Centre Jean Perrin
Phone: 0473278005
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identify new candidate genes for hereditary cancer predisposition in patients with uveal melanoma by constitutional exome analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.